These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

644 related articles for article (PubMed ID: 26319344)

  • 41. [Does acetylsalicylic acid and vitamin K antagonists are risk factors of macular degeneration related with age?].
    Jończyk-Skórka K; Śliwczyńska-Rodziewicz D; Jarmak A; Kowalski J
    Pol Merkur Lekarski; 2015 Mar; 38(225):144-9. PubMed ID: 25815614
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Age related macular degeneration - new developments in treatment.
    Smith TC; Lee L
    Aust Fam Physician; 2007 May; 36(5):359-61. PubMed ID: 17492074
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Development of gene therapy for treatment of age-related macular degeneration.
    Askou AL
    Acta Ophthalmol; 2014 Jul; 92 Thesis3():1-38. PubMed ID: 24953666
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Age-related macular degeneration in a screened South Korean population: prevalence, risk factors, and subtypes.
    Song SJ; Youm DJ; Chang Y; Yu HG
    Ophthalmic Epidemiol; 2009; 16(5):304-10. PubMed ID: 19874110
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Incidence of exudative age-related macular degeneration among elderly Americans.
    Javitt JC; Zhou Z; Maguire MG; Fine SL; Willke RJ
    Ophthalmology; 2003 Aug; 110(8):1534-9. PubMed ID: 12917168
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The quest to conquer age-related macular degeneration.
    Bryan RG
    Med Health R I; 2008 Feb; 91(2):51-3, 56. PubMed ID: 18372860
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Polymorphisms in the vascular endothelial growth factor gene and risk of age-related macular degeneration: the Rotterdam Study.
    Boekhoorn SS; Isaacs A; Uitterlinden AG; van Duijn CM; Hofman A; de Jong PT; Vingerling JR
    Ophthalmology; 2008 Nov; 115(11):1899-903. PubMed ID: 18708255
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Age-related macular degeneration in Onitsha, Nigeria.
    Nwosu SN
    Niger J Clin Pract; 2011; 14(3):327-31. PubMed ID: 22037079
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Overview of progress in the epidemiology of age-related macular degeneration.
    Klein R
    Ophthalmic Epidemiol; 2007; 14(4):184-7. PubMed ID: 17896295
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prevalence of age-related macular degeneration in an elderly urban chinese population in China: the Jiangning Eye Study.
    Ye H; Zhang Q; Liu X; Cai X; Yu W; Yu S; Wang T; Lu W; Li X; Jin H; Hu Y; Kang X; Zhao P
    Invest Ophthalmol Vis Sci; 2014 Sep; 55(10):6374-80. PubMed ID: 25190650
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Diabetes, cardiovascular morbidity, and risk of age-related macular degeneration in a primary care population.
    Vassilev ZP; Ruigómez A; Soriano-Gabarró M; García Rodríguez LA
    Invest Ophthalmol Vis Sci; 2015 Feb; 56(3):1585-92. PubMed ID: 25670489
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Interventions for Age-Related Macular Degeneration: Are Practice Guidelines Based on Systematic Reviews?
    Lindsley K; Li T; Ssemanda E; Virgili G; Dickersin K
    Ophthalmology; 2016 Apr; 123(4):884-97. PubMed ID: 26804762
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prevalence of Age-Related Macular Degeneration in Slovakia and Associated Risk Factors: A Mobile Clinic-Based Cross-Sectional Epidemiological Survey.
    Krasnik V; Stefanickova J; Popov I; Valaskova J; Saxena S; Kruzliak P
    Semin Ophthalmol; 2018; 33(4):506-511. PubMed ID: 28524715
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Age-related macular degeneration, anti-vascular endothelial growth factor agents, and short-term mortality: a postmarketing medication safety and surveillance study.
    French DD; Margo CE
    Retina; 2011 Jun; 31(6):1036-42. PubMed ID: 21836410
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Age-related macular degeneration. Can we stem this worldwide public health crisis?
    Starr CE; Guyer DR; Yannuzzi LA
    Postgrad Med; 1998 May; 103(5):153-6, 161-4. PubMed ID: 9590992
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Recognizing age-related macular degeneration in primary care.
    Cunningham J
    JAAPA; 2017 Mar; 30(3):18-22. PubMed ID: 28151737
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Treatment of retinal angiomatous proliferation in age-related macular degeneration: a series of 104 cases of retinal angiomatous proliferation.
    Bottoni F; Massacesi A; Cigada M; Viola F; Musicco I; Staurenghi G
    Arch Ophthalmol; 2005 Dec; 123(12):1644-50. PubMed ID: 16344434
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Age-related macular degeneration--emerging pathogenetic and therapeutic concepts.
    Gehrs KM; Anderson DH; Johnson LV; Hageman GS
    Ann Med; 2006; 38(7):450-71. PubMed ID: 17101537
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Age-Related Macular Degeneration: Pathophysiology, Management, and Future Perspectives.
    Flores R; Carneiro Â; Vieira M; Tenreiro S; Seabra MC
    Ophthalmologica; 2021; 244(6):495-511. PubMed ID: 34130290
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Population-based incidence of exudative age-related macular degeneration and ranibizumab treatment load.
    Geirsdottir A; Jonsson O; Thorisdottir S; Helgadottir G; Jonasson F; Stefansson E; Sigurdsson H
    Br J Ophthalmol; 2012 Mar; 96(3):444-7. PubMed ID: 21856691
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.